Feasibility for active surveillance in biopsy Gleason 3 + 4 prostate cancer: an Australian radical prostatectomy cohort

Brachytherapy: state-of-the-art radiotherapy in prostate cancer

(2015) Michael W.T. Chao et al.   BJU INTERNATIONAL

The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry

(2015) Mahesha Weerakoon et al.   BJU INTERNATIONAL

How Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review

(2015) Lara Bellardita et al.   EUROPEAN UROLOGY

A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer

(2015) Jennifer Cullen et al.   EUROPEAN UROLOGY

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

(2015) Laurence Klotz et al.   JOURNAL OF CLINICAL ONCOLOGY

The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates

(2015) R Schiavina et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

(2015) Guillaume Ploussard et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Anxiety in the management of localised prostate cancer by active surveillance

(2014) Jake Anderson et al.   BJU INTERNATIONAL

Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies

(2014) Morgan R. Pokorny et al.   EUROPEAN UROLOGY

A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer

(2013) Sanoj Punnen et al.   BJU INTERNATIONAL

The impact of baseline [−2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort

(2013) Hiromi Hirama et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy

(2012) L-M Wong et al.   BRITISH JOURNAL OF CANCER

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

(2012) Meelan Bul et al.   EUROPEAN UROLOGY

Association of [−2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer

(2012) Jeffrey J. Tosoian et al.   JOURNAL OF UROLOGY

Impact of Multiparametric Endorectal Coil Prostate Magnetic Resonance Imaging on Disease Reclassification Among Active Surveillance Candidates: A Prospective Cohort Study

(2012) David Margel et al.   JOURNAL OF UROLOGY

Targeted Biopsy in the Detection of Prostate Cancer Using an Office Based Magnetic Resonance Ultrasound Fusion Device

(2012) Geoffrey A. Sonn et al.   JOURNAL OF UROLOGY

Active Surveillance for Prostate Cancer: Progress and Promise

(2011) Matthew R. Cooperberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Diffusion-Weighted MRI of Peripheral Zone Prostate Cancer: Comparison of Tumor Apparent Diffusion Coefficient With Gleason Score and Percentage of Tumor on Core Biopsy

(2010) Courtney A. Woodfield et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer

(2010) Matthew R. Cooperberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Currently used criteria for active surveillance in men with low-risk prostate cancer

(2008) Nazareno Suardi et al.   CANCER